Curie.Bio
Venture capitalActively deployingCambridge · Seed–Series A · 7 people tracked
Also known as CURIE BIO OPERATIONS, LLC · Curie Bio Seed
Investment thesis
Curie.Bio is a venture capital firm that invests in early-stage biotech therapeutics companies.
Source: firm website, verified Aug 11, 2026.
Team · 7 people
from public directories
What they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathImproving patients' lives by accelerating development and commercialization of medicines that matter.
BiotechCambridge, US
Thomas Catinazzo(Executive Officer)Peter Rahmer(Executive Officer)Sekar Kathiresan(Director)Douglas S. Ingram(Director)Sanjiv K. Patel(Executive Officer, Director)Mark Murcko(Director)
Board seatAlexis Borisy· per SEC Form D · $30M raise · filed Jan 2024
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioRelay TherapeuticsNASDAQ: RLAY
Frequently asked questions
- What stage does Curie.Bio invest at?
- Curie.Bio invests at the Seed, Series A stages.
- What is Curie.Bio's typical check size?
- Curie.Bio typically writes checks of $7M.
- What sectors does Curie.Bio focus on?
- Curie.Bio focuses on Biotech.
- Where is Curie.Bio located?
- Curie.Bio is headquartered in Cambridge, US.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.